Alexander Haug, PhD

Alexander Haug is an Associate Professor of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine and Deputy Head of the Division of Nuclear Medicine. His research focuses are the use of theranostics, particularly in neuroendocrine tumors, PET-imaging of specific biomarkers such as the CXCR4 receptor with a prognostic or predictive impact in cancer, and machine learning approaches for improving the impact of imaging.

Dr. Haug has a track record in oncologic hybrid imaging. He is PI of several studies, mainly dealing with radionuclide-therapy and oncologic  imaging with PET/CT and PET/MRI. He currently supervises 2 PhD students and has successfully supervised 7 “Dr. med.” projects.

Go back

HYBRID2020 Consortium |
© All Rights Reserved Imprint & Data Policy